Dr Natalie Gunn is the Healthcare Lead at IBM Research Australia. She joined IBM Research Australia in 2012. The lab had just started and was made up of a vibrant team of early career researchers and software engineers.
Natalie began as a technical researcher tasked with producing raw materials for subsequent analysis on silicon chips at the nanoscale. She was part of a team looking at high-throughput screening of a hugely important drug target group at the single molecule level. Upon conclusion of that project, Natalie took over management of a team of computer scientists and engineers and began to develop an agenda around Artificial Intelligence solutions for Eye Health. Today, she is passionate about developing AI that delivers value for individuals, communities and IBM.